European society of contraception statement on contraception in obese women
- PMID: 25380138
- DOI: 10.3109/13625187.2014.960561
European society of contraception statement on contraception in obese women
Abstract
The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.
Keywords: Contraceptive failure; Depo-medroxyprogesterone; Efficacy; Hormonal contraception; Obesity; Progestin-only contraception; Thromboembolic risk; Weight.
Similar articles
-
Obesity and contraception: metabolic changes, risk of thromboembolism, use of emergency contraceptives, and role of bariatric surgery.Minerva Ginecol. 2013 Jun;65(3):279-88. Minerva Ginecol. 2013. PMID: 23689170 Review.
-
Hormonal contraception and obesity.Fertil Steril. 2016 Nov;106(6):1282-1288. doi: 10.1016/j.fertnstert.2016.07.1094. Epub 2016 Aug 23. Fertil Steril. 2016. PMID: 27565257 Review.
-
Controversies in contraception.Curr Opin Pediatr. 2008 Aug;20(4):383-9. doi: 10.1097/MOP.0b013e328305e13f. Curr Opin Pediatr. 2008. PMID: 18622191 Review.
-
Cancer and contraception. Release date May 2012. SFP Guideline #20121.Contraception. 2012 Sep;86(3):191-8. doi: 10.1016/j.contraception.2012.05.008. Epub 2012 Jun 7. Contraception. 2012. PMID: 22682881
-
The contraception needs of the perimenopausal woman.Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):903-15. doi: 10.1016/j.bpobgyn.2014.05.006. Epub 2014 Jun 5. Best Pract Res Clin Obstet Gynaecol. 2014. PMID: 24990143
Cited by
-
Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non-Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline.Int J Gynaecol Obstet. 2020 Sep;151 Suppl 1(Suppl 1):16-36. doi: 10.1002/ijgo.13334. Int J Gynaecol Obstet. 2020. PMID: 32894590 Free PMC article. Review. No abstract available.
-
Clinical Practice Guidelines for Childbearing Female Candidates for Bariatric Surgery, Pregnancy, and Post-partum Management After Bariatric Surgery.Obes Surg. 2019 Nov;29(11):3722-3734. doi: 10.1007/s11695-019-04093-y. Obes Surg. 2019. PMID: 31493139 Review.
-
Assessment of Contraceptive Counseling and Contraceptive Use in Women After Bariatric Surgery.Obes Surg. 2019 Dec;29(12):4029-4035. doi: 10.1007/s11695-019-04084-z. Obes Surg. 2019. PMID: 31290113
-
Progestin-only contraceptives: effects on weight.Cochrane Database Syst Rev. 2016 Aug 28;2016(8):CD008815. doi: 10.1002/14651858.CD008815.pub4. Cochrane Database Syst Rev. 2016. PMID: 27567593 Free PMC article. Review.
-
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery.Open Access J Contracept. 2016 Sep 29;7:143-150. doi: 10.2147/OAJC.S84097. eCollection 2016. Open Access J Contracept. 2016. PMID: 29386945 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials